πŸ‡ΊπŸ‡Έ FDA
Patent

US 6369080

Selective factor Xa inhibitors

expired A61PA61P7/02

Quick answer

US patent 6369080 (Selective factor Xa inhibitors) held by COR Therapeutics, Inc. expires Mon Apr 04 2022 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
COR Therapeutics, Inc.
Grant date
Tue Apr 09 2002 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 04 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
46
CPC classes
A61P, A61P7/02